Seres Therapeutics, Inc. (NASDAQ:MCRB)
Seres Therapeutics, Inc. (NASDAQ:MCRB) represented a move of 0 percent or $0.14 per share and closed its previous day trading session at $8.01. 0 Shares were traded in the last trading session with an Average Volume of 114.91 Million Shares. The stock currently has a Market Capitalization of 344.51 Million.
Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
The stock traded between $ 5.64 and $11.35 over 1-Year time period showing its price to sales ratio of 16.64. Seres Therapeutics, Inc. (NASDAQ:MCRB) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $8.34 and 200-Day Simple Moving Average of $-0.94. Its Price to Free Cash Flow is 0 and Price to Book of 0.
Analyst’s recommended the stock as 2.1 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Seres Therapeutics, Inc. (NASDAQ:MCRB) reported its Actual EPS of $-0.54/share. The analysts offering Earnings Estimates for the company were believing that Seres Therapeutics, Inc. could bring EPS of $-0.52/share. The difference between Actual EPS and Estimated EPS was -0.02 Percent. Thus showing an Earnings Surprise of -3.8 Percent.
Lithium Americas Corp. (NYSE:LAC)
In the last trading session, Lithium Americas Corp. (NYSE:LAC) added its value by 0% closing at the price of $3.76. The stock currently has market capitalization of 333.1 Million, with average volume of 177.97 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Lithium Americas Corp. (NYSE:LAC) is showing beta of 0. This particular value of beta suggests that Lithium Americas Corp. (NYSE:LAC) has historically moved 0% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Lithium Americas Corp. (NYSE:LAC) is at $-0.28.
The stock currently has RSI of 45.26. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Lithium Americas Corp. owns Lithium Nevada and RheoMinerals Inc., a supplier of rheology modifiers for oilbased drilling fluids, coatings and specialty chemicals. Lithium Americas Corp. is based in Vancouver, Canada.
Lithium Americas Corp. (NYSE:LAC) topped its 52-week high price of $10.39 on 01/09/18 and 52-Week Low Price of $ 3.04 on 10/31/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.84% and monthly volatility of 6.03% respectively.